SUMMER WALKER: Open Payments
NPI 1912604307 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 21 payments from 8 companies in 2025. Trend: 2023 $220 · 2024 $174 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $346 |
| Novartis Pharmaceuticals Corporation | 4 | $94 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $39 |
| Exact Sciences Corporation | 1 | $28 |
| SANOFI PASTEUR INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: AIRSUPRA, LEQVIO, VERQUVO, MOUNJARO, Wegovy, The Cologuard Plus Collection Kit, BEYFORTUS, FARXIGA.
Industry payments across CA — which companies pay providers there.
